Two Sigma Advisers’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443K | Sell |
260,800
-15,300
|
|
||||
|
2025
Q1 | $436K | Buy |
276,100
+193,500
|
|
||||
|
2024
Q4 | $148K | Buy |
+82,600
|
|
||||
|
2023
Q4 | – | Sell |
-56,900
|
|
||||
|
2023
Q3 | $176K | Sell |
56,900
-25,400
|
|
||||
|
2023
Q2 | $222K | Sell |
82,300
-141,500
|
|
||||
|
2023
Q1 | $665K | Buy |
223,800
+51,700
|
|
||||
|
2022
Q4 | $434K | Sell |
172,100
-170,300
|
|
||||
|
2022
Q3 | $623K | Buy |
342,400
+291,300
|
|
||||
|
2022
Q2 | $161K | Sell |
51,100
-61,900
|
|
||||
|
2022
Q1 | $698K | Sell |
113,000
-43,500
|
|
||||
|
2021
Q4 | $2.22M | Sell |
156,500
-408,300
|
|
||||
|
2021
Q3 | $4.52M | Buy |
564,800
+525,000
|
|
||||
|
2021
Q2 | $1.14M | Buy |
39,800
+19,700
|
|
||||
|
2021
Q1 | $584K | Buy |
+20,100
|
|